Rwanda vs United Kingdom: Access to anti-retroviral drugs, female (%)
Rwanda
97.0%
in 2024
United Kingdom
96.0%
in 2023
Rwanda rank
12th
United Kingdom rank
14th
Access to anti-retroviral drugs, female (%) over time
- Rwanda
- United Kingdom
How they compare
Rwanda currently reports 97.0% against 96.0% in United Kingdom, a difference of 1.0%.
Across all 8 years both countries report, United Kingdom has been ahead every year.
Rwanda ranks 12th and United Kingdom ranks 14th of 141 countries.
United Kingdom has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Rwanda | United Kingdom | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.5% | 88.0% | 9.5% | United Kingdom |
| 2020s | 89.2% | 90.8% | 1.5% | United Kingdom |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Rwanda or United Kingdom?
- Rwanda, at 97.0% against 96.0% in United Kingdom as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Rwanda and United Kingdom?
- 1.0%, with Rwanda ahead.
- How many years of comparable data are there for Rwanda and United Kingdom?
- 8 years are reported by both, from 2016 to 2023.
- How do Rwanda and United Kingdom rank globally for access to anti-retroviral drugs, female?
- Rwanda ranks 12th and United Kingdom ranks 14th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.